Defective packaging non-oncoviral vectors based on mpmv and hiv

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/867 (2006.01) C07K 14/15 (2006.01) C07K 14/16 (2006.01) C12N 7/04 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2117607

Novel vectors are capable of producing MPMV (Mason-Pfizer Monkey Virus) proteins but not of packaging MPMV RNA, and the information about the packaging signal in MPMV and HIV can be used to create MPMV and HIV vectors that are capable of transferring foreign genes, e.g. for use in gene therapy.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Defective packaging non-oncoviral vectors based on mpmv and hiv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Defective packaging non-oncoviral vectors based on mpmv and hiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Defective packaging non-oncoviral vectors based on mpmv and hiv will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1578976

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.